Related Experiment Videos

[Does methylmethacrylate induce cardiovascular complications during alloarthroplastic surgery of the hip joint?

Der Anaesthesist
|February 1, 1976
PubMed

Insights

Monomethylacrylate does not directly depress cardiac function. Cardiovascular events linked to endoprostheses stem from a vagotropic effect and bone marrow pressure, preventable with prophylactic measures.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Physiology
  • Toxicology

Context:

  • Endoprosthetic device implantation can lead to transient cardiovascular changes.
  • The role of methacrylate compounds in these events requires clarification.
  • Bone marrow pressure during implantation is a potential risk factor.

Purpose:

  • To investigate the direct cardiac effects of monomethylacrylate.
  • To elucidate the mechanisms behind cardiovascular incidents during endoprosthesis surgery.
  • To identify effective prophylactic strategies against these complications.

Summary:

  • Cardiovascular experiments in dogs and rabbits revealed monomethylacrylate lacks direct cardiac depressant activity.
  • Transient decreases in blood pressure and heart rate are attributed to the vagotropic effects of methacrylates, antagonized by atropine.
  • Severe events, including acute cor pulmonale, are linked to bone marrow pressure during endoprosthesis insertion, causing intravasation and coagulation.

Impact:

  • Findings clarify the safety profile of monomethylacrylate in cardiovascular contexts.
  • Demonstrates the efficacy of atropine in mitigating methacrylate-induced vagotropic effects.
  • Highlights the importance of prophylactic procedures in preventing fatal cardiovascular complications during endoprosthesis surgery.

Related Concept Videos